Nationwide Recall of Cipla Albuterol Aerosol Inhalers

Cipla Issues Voluntary Nationwide Recall of Six Batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) Due to Container Defect FOR IMMEDIATE RELEASE - Mumbai, India July 6, 2023/ New Jersey, USA July 6, 2023 – Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla"), today announced that its wholly-owned subsidiary Cipla US is voluntarily recalling six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) manufactured in November 2021 to the consumer level.

Sr. No. Product Name Batch No. Expiry Date

1. Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)IB20045Nov.2023

2. Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)IB20055Nov.2023

3. Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)IB20056Nov.2023

4. Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)IB20057Nov.2023

5. Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)IB20059Nov.2023

6. Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)IB20072Nov.2023